RecruitingPhase 2NCT04436081

Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

Sponsor

Eastern Virginia Medical School

Enrollment

40 participants

Start Date

Feb 26, 2021

Study Type

INTERVENTIONAL

Conditions

Dementia Alzheimer Disease Major Neurocognitive Disorder With Aggressive Behavior

Summary

This is a randomized, double-blinded, placebo-controlled, crossover trial that aims to 1) determine the efficacy of THC-free cannabidiol (CBD oil) in reducing the severity of agitation among participants and 2) determine whether THC-free CBD oil can reduce the burden on caregivers and increase the participants' quality of life.

Eligibility

Min Age: 50 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Placebo and a drug called THC-free CBD Oil for people with alzheimer disease, dementia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 50 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.